HRSA Delays 340B Drug Discount Rule

The Health Resources and Services Administration has delayed the compliance date for a rule prohibiting certain hospitals participating in the 340B drug discount pricing program from purchasing outpatient drugs through group purchasing organizations, according to an AHA News Now report.

Advertisement

The rule, affecting disproportionate share hospitals, children’s hospitals and free-standing cancer hospitals, has a new compliance date of August 7, 2013 (originally April 7, 2013). No extensions will be granted beyond August 7.  

A delay had been requested by the AHA and 340B hospital members, to allow for more time to work with vendors and update inventory management systems.

More Articles on 340B Programs:

AHA Wants to Delay Rule Prohibiting Some Hospitals From Obtaining Drugs Through GPOs
Sen. Grassley Targets Duke, UNC, Carolinas Hospitals for Use of Discount Drug Program
Is Your 340B Program Prepared for an Audit?  

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.